What is SmartLabs?
Founded in 2015 and headquartered in Boston, Massachusetts, SmartLabs specializes in creating pharma-grade research environments tailored for companies of all sizes. The company aims to streamline the operational and logistical complexities that arise as research teams scale. SmartLabs offers a comprehensive suite of services, including in-house design, architecture, and construction management, alongside full-service facilities management and shared amenities, thereby minimizing administrative burdens for its clients.
How much funding has SmartLabs raised?
SmartLabs has raised a total of $387.8M across 4 funding rounds:
Angel/Seed
$8.8M
Series A
$81M
Series B
$250M
Series C
$48M
Angel/Seed (2015): $8.8M, investors not publicly disclosed
Series A (2020): $81M, investors not publicly disclosed
Series B (2021): $250M supported by Winslow Capital Management, Breed’s Hill Capital, Conversion Venture Capital, Onex Falcon, and ArrowMark Partners
Series C (2024): $48M featuring Conversion Venture Capital, Winslow Capital Management, and ArrowMark Partners
Key Investors in SmartLabs
Conversion Venture Capital
Conversion Venture Capital is a private equity and venture capital firm focused on building segment-leading businesses by providing flexible, patient capital and emphasizing value creation and long-term partnerships.
Winslow Capital Management
Winslow Capital Management is a premier growth equity investment firm established in 1992, headquartered in Minneapolis, Minnesota.
ArrowMark Partners
ArrowMark Partners is an employee-owned asset manager specializing in alternative credit and growth equity, providing services primarily to investment companies since its establishment in 2007.
What's next for SmartLabs?
The recent major enterprise-level funding, particularly the strategic investment, signals a pivotal growth phase for SmartLabs. This capital is likely to fuel further expansion of its service offerings, enhance its technological infrastructure, and potentially broaden its market reach. The company's focus on reducing operational friction for research-intensive organizations positions it well for continued development and scaling within the life sciences and biotechnology sectors.
See full SmartLabs company page
